EQUITY RESEARCH MEMO

Interrad Medical

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

Interrad Medical is a private medical device company based in Plymouth, MN, focused on catheter securement solutions with its flagship product, SecurAcath. The company recently published results from the SECURED randomized clinical trial, demonstrating that SecurAcath is superior to standard of care in preventing dislodgement of non-cuffed central venous catheters in pediatric patients. Founded in 2006, the company operates in the competitive medical devices space, targeting a significant clinical problem. While financial details and commercialization stage are not publicly disclosed, the positive clinical data positions SecurAcath as a potential new standard. However, the company faces challenges in market penetration and regulatory expansion. Overall, Interrad Medical shows promise but requires further validation and commercial execution.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)